Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time
Statistics in Medicine · 2026-05 · 45 (10-12)
DOI: 10.1002/sim.70563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 24.04.2026. Verfasst von Jianhong Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation, National Medical Products Administration, Beijing, China. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sequential multiple assignment randomized trials (SMART) designs, which are used to evaluate adaptive treatment strategies (ATSs), involve multiple stages of patient randomization based on intermediate outcomes. While offering greater flexibility and personalization in treatment, these designs are often analytically complex and resource‐intensive—especially when survival outcomes are involved, given the extended follow‐up times and potential violations of proportional hazards assumptions. To address these challenges, we propose a statistical inference framework based on restricted mean survival time (RMST). RMST does not rely on the proportional‐hazards assumption and serves as a robust summary for survival data. The framework includes fixed‐ and dynamic‐weight RMST estimators, their variance–covariance structures, confidence intervals, and hypothesis tests for pairwise and global comparisons among ATSs. We also integrate interim analyses into SMART designs using RMST and develop a type I error‐control method that accommodates the lack of the independent‐increments property. Extensive simulations demonstrate good estimator performance and show that interim designs can reduce either sample size or trial duration. In summary, this study offers an efficient and practical framework for SMART trials with survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation, National Medical Products Administration, Beijing, China.
- State Key Laboratory of Multi-Organ Injury Prevention and Treatment, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
ORCID-Profile: Minggang Yin, Chongyang Duan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pan, J., Yu, S., Yin, M., Yang, Y., & Duan, C. (2026). Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time. Statistics in Medicine, 45(10-12). https://doi.org/10.1002/sim.70563
Vancouver
Pan J, Yu S, Yin M, Yang Y, Duan C. Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time. Statistics in Medicine. 2026;45(10-12). doi:10.1002/sim.70563
BibTeX
@article{Pan2026,
author = {Pan, Jianhong and Yu, Shijie and Yin, Minggang and Yang, Yuxuan and Duan, Chongyang},
title = {Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time},
journal = {Statistics in Medicine},
year = {2026},
volume = {45},
number = {10-12},
doi = {10.1002/sim.70563}
}
EUVIMED